Medical News Today -
12 Sep 2013 11:00
A new meningitis vaccine (MenAfriVac) is highly effective at protecting against epidemic A meningococcal disease, common in Africa's meningitis belt where it accounts for at least three quarters of cases, and against transmission of the bacterium that causes these epidemics, according to new research published in The Lancet. One shot of MenAfriVac dramatically reduced incidence of all cases of meningitis by 94% and carriage prevalence of the epidemic strain by 98%, while an epidemic persisted in...
Share this Article